Diagnosis and treatment of severely malnourished children with diarrhoea
Lora L Iannotti1, Indi Trehan, Kathryn L Clitheroe
1Institute for Public Health, George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri.
Insights
Effective management of severe acute malnutrition in children with diarrhea involves specific diagnostic and therapeutic strategies. Key findings include using diarrhea duration as a marker, rapid hypoglycemia diagnosis, and benefits from antiparasitic medication and specialized diets.
Area of Science:
- Pediatrics
- Infectious Diseases
- Nutritional Science
Background:
- Children with severe acute malnutrition (SAM) and diarrhea face heightened mortality risks.
- Effective community-based management strategies for SAM with diarrhea are critical but under-researched.
- Physiological vulnerability in this population necessitates specialized care approaches.
Purpose of the Study:
- To systematically review diagnostic and therapeutic measures for community-based management of SAM in children with diarrhea.
- To identify evidence-based interventions, broadening the search to include inpatient care due to limited direct studies.
Main Methods:
- Systematic literature review conducted from 1950 to 2013.
- Initial search focused on community-based management, expanded to inpatient settings.
- 129 studies were identified, with 32 selected for full review, noting limitations like indirectness, inconsistency, and bias.
Main Results:
- Diagnostic indicators include prolonged/persistent diarrhea, rapid hypoglycemia detection, and the role of Cryptosporidium.
- Therapeutic benefits suggested for routine antiparasitic medication, ready-to-use therapeutic foods, lactose-free diets, and zinc supplementation.
- Existing rehydration guidelines were supported; glutamine and low osmolarity feeds showed inconclusive utility.
Conclusions:
- Evidence supports specific diagnostic markers and therapeutic interventions for SAM children with diarrhea.
- Routine antiparasitic medication, specialized feeding (RUTFs, lactose-free, zinc), and established rehydration are recommended.
- Further research is needed to clarify the role of glutamine and low osmolarity feeds in this vulnerable population.
Abstract:
Children with severe acute malnutrition complicated by diarrhoea require special care due to their unique physiological vulnerability and increased mortality risks. A systematic literature review (1950-2013) was conducted to identify the most effective diagnostic and therapeutic measures for the community-based management of severely malnourished children with diarrhoea. No studies directly addressed this question, so the search was broadened to include inpatient care. Of the 129 studies identified, 32 were selected for full review and found to contain varying degrees of indirectness, inconsistency and bias. Evidence from diagnostic studies point to the use of both prolonged and persistent diarrhoea as morbidity markers, rapid hypoglycaemia diagnosis and the frequent aetiological role of Cryptosporidium. Therapeutic studies suggest benefits from routine antiparasitic medication and feeding regimens with ready-to-use-therapeutic foods, lactose-free diets and zinc supplementation. Existing rehydration treatment guidelines were affirmed, but the utility of glutamine and low osmolarity feeds were inconclusive.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Fungal Phylum Microsporidia


